Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that ...

Scientists use a precise form of gene editing called prime editing to correct the most common genetic mutations that cause alternating hemiplegia of childhood, a rare and severe neurological disorder ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

A study comparing the gene expression signature of Alzheimer's disease with those elicited by 1,300 approved drugs found a combination of two cancer medications that could treat the most common form ...

A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe ...

Scientists have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer’s ...

By the time they are a few months old, infants born with alternating hemiplegia of childhood (AHC) begin experiencing ...

Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that ...

Dr William Davies, discusses updated international guidelines for the management of congenital ichthyoses, including X-linked ...

New RNA vaccine shows promise in turning resistant tumors into immunotherapy targets. Study offers hope for more effective, ...